ArticleCancer chemotherapy and pharmacology2026
A pharmacokinetic-pharmacodynamic/toxicodynamic model framework for PARP inhibitor combination therapy with DNA-damaging chemotherapeutics.
Li Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.